Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 314.80M | £ 336.80M | £ 350.70M | £ 457.00M | £ 371.30M |
Total Assets | £ 4.39B | £ 4.14B | £ 3.74B | £ 3.79B | £ 3.77B |
Total Debt | £ 1.47B | £ 1.45B | £ 1.06B | £ 1.43B | £ 1.34B |
Net Debt | £ 1.16B | £ 1.11B | £ 709.00M | £ 971.60M | £ 965.70M |
Total Liabilities | £ 3.01B | £ 2.83B | £ 2.37B | £ 2.57B | £ 2.44B |
Stockholders Equity | £ 1.35B | £ 1.29B | £ 1.35B | £ 1.19B | £ 1.32B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |